Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Axsome Therapeutics (AXSM) Tax Rate (2017 - 2025)

Axsome Therapeutics recorded quarterly Tax Rate of 1.64% in Q4 2025, down 180.02% quarter-over-quarter from 2.04% in Q2 2025, and down 152.0% year-over-year from 3.14% in Q4 2024.

Axsome Therapeutics' Tax Rate history runs 5 years deep, the most recent figure standing at 1.64% for Q4 2025.

  • In Q4 2025, Tax Rate fell 152.0% year-over-year to 1.64%; the TTM figure through Mar 2026 stood at 0.29% (up 32.0% YoY), while the FY2025 annual figure was 0.27%, up 30.0% from the prior year.
  • Tax Rate came in at 1.64% for Q4 2025 at Axsome Therapeutics, down from 2.04% in the prior quarter.
  • In the past five years, Tax Rate ranged from a high of 2.04% in Q2 2025 to a low of 30.1% in Q1 2023.
  • A 3-year average of 3.93% and a median of 0.33% in 2023 frame the typical range for Tax Rate.
  • Across the five-year window, Tax Rate tumbled 44 bps in 2024 and tumbled 152 bps in 2025, its largest moves.
  • Axsome Therapeutics' Tax Rate stood at 0.33% in 2023, then plunged by 135 bps to 0.11% in 2024, then sank by 1340 bps to 1.64% in 2025.
  • According to Business Quant data, Tax Rate over the past three periods registered 1.64%, 2.04%, and 0.11% for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Tax Rate (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 57.14
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 5.61
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 17.68
7 Evaxion A 62.56 Bn 62.54 Bn - -6.79
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 12.51
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 7.07
10 Axsome Therapeutics 11.82 Bn 11.51 Bn 176.48 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -1.64
Dec 31, 2025 -1.64
Jun 30, 2025 2.04
Jun 30, 2025 2.04
Dec 31, 2024 -0.11
Dec 31, 2024 -0.11
Dec 31, 2023 0.33
Dec 31, 2023 0.33
Sep 30, 2023 1.08
Sep 30, 2023 1.08
Jun 30, 2023 0.89
Jun 30, 2023 0.89
Mar 31, 2023 -30.10
Mar 31, 2023 -30.10
Sep 30, 2018 2.55
Sep 30, 2018 2.55
Sep 30, 2017 -3.48
Sep 30, 2017 -3.48